CDKN1A and breast carcinoma: The study by Cai et al. [58] revealed the ability of tricin to arrest breast cancer cells in the G2/M phase of the cell cycle through modulating the cell cycle protein regulators, such as p34cdc2, Wee1 and p21cip1.